Mainstream regulator
WHO
The WHO is the most common mainstream reference for public EMF health summaries and the WHO International EMF Project.
Origin
United Nations
Year
2016
Source reference
WHO Radiation: Electromagnetic Fields Q&A (2016)
What it found
WHO fact sheets generally state that no adverse health effects have been conclusively established below recognized international guideline limits.
What it did not prove
That position does not erase the WHO's own IARC classification, court remands, stricter national standards, or unresolved long-term questions.
What critics say
Critics argue WHO summaries can understate uncertainty by leaning on guideline bodies while giving less public attention to precautionary evidence.
Why groups differ
WHO public guidance tends to require strong causal evidence, while precautionary groups may act on limited evidence, vulnerable-population concerns, or policy uncertainty.
RADIHALT Takeaway
Why does practical shielding stay smart?
RADIHALT treats WHO as important context, not the only voice. Practical copper-nickel shielding gives buyers extra control without relying on fear claims.
Shop RADIHALT on AmazonBest used for
- Mainstream public-health context
- Contrasting WHO and IARC positions
- Avoiding one-sided EMF claims
Evidence checklist
- Do not treat one regulator, country, or study group as the final answer on EMF exposure.
- Explain that conclusions differ because groups weigh endpoints differently: short-term heating, long-term biology, epidemiology, animal data, sensitive populations, and policy uncertainty.
- Use mainstream agencies only as one evidence layer, never as RADIHALT's editorial conclusion or as proof that a shielding product is unnecessary.
- When health or safety interpretation is discussed, pair mainstream context with both stricter national or precautionary frameworks and independent or peer-reviewed research.
Related Sources
Build the balanced evidence map
World Health Organization - 2011
IARC (Group 2B classification)
Group 2B means 'possibly carcinogenic to humans' based on limited evidence in humans plus animal data. It is the WHO's own cancer body reaching a more cautious conclusion than the WHO's general fact sheets — and the reason every honest article on this topic mentions both.
International (WHO-recognized) - 2020
ICNIRP
A major international reference for evidence review and limit-setting. The 2020 guidelines replaced the 1998 RF guidance and should be read alongside the separate U.S. FCC framework and precautionary critiques.
International (IARC-led) - 2024
COSMOS prospective cohort
Important because it is one of the strongest mainstream epidemiology updates: the 2024 COSMOS brain-tumor analysis did not find higher glioma, meningioma, or acoustic neuroma risk among the highest-call-time users. It should be cited as part of the mainstream evidence layer while noting that exposure classification, follow-up length, and changing wireless habits remain debated.
What is the practical meaning of WHO?
RADIHALT treats WHO as important context, not the only voice. Practical copper-nickel shielding gives buyers extra control without relying on fear claims.
Does WHO settle the EMF debate?
That position does not erase the WHO's own IARC classification, court remands, stricter national standards, or unresolved long-term questions.
How should readers use this source?
Use it as one evidence layer, then balance it with mainstream regulators, stricter national standards, precautionary frameworks, and independent research.
